Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.16B | 8.55B | 8.42B | 8.05B | 8.10B |
Gross Profit | 4.69B | 4.89B | 4.70B | 4.53B | 4.12B |
EBITDA | 1.33B | 1.37B | 1.48B | 1.10B | 309.00M |
Net Income | 733.00M | 533.00M | 755.00M | 422.00M | -129.00M |
Balance Sheet | |||||
Total Assets | 25.72B | 25.60B | 24.61B | 24.26B | 23.97B |
Cash, Cash Equivalents and Short-Term Investments | 10.72B | 10.80B | 10.67B | 10.48B | 10.47B |
Total Debt | 380.00M | 480.00M | 480.00M | 530.00M | 430.00M |
Total Liabilities | 3.24B | 3.70B | 3.52B | 3.19B | 2.96B |
Stockholders Equity | 22.48B | 21.90B | 21.08B | 21.07B | 21.01B |
Cash Flow | |||||
Free Cash Flow | 548.00M | 688.00M | 1.13B | 273.00M | 207.00M |
Operating Cash Flow | 880.00M | 997.00M | 1.54B | 1.02B | 680.00M |
Investing Cash Flow | -575.00M | -416.00M | -404.00M | -765.00M | 26.00M |
Financing Cash Flow | -387.00M | -449.00M | -946.00M | -248.00M | -252.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥16.50B | 11.80 | 3.25% | 5.89% | 11.19% | ||
76 Outperform | ¥15.35B | 18.06 | 2.12% | -4.20% | 64.56% | ||
75 Outperform | ¥14.66B | 12.63 | 1.96% | 6.56% | 59.11% | ||
66 Neutral | ¥12.75B | 14.53 | 4.87% | 1.93% | -1.93% | ||
63 Neutral | £1.74B | 10.54 | 4.37% | 3.49% | 0.66% | -39.52% | |
59 Neutral | ¥15.91B | 22.65 | 2.65% | 1.27% | -43.97% | ||
41 Neutral | ¥12.29B | ― | ― | 48.75% | -620.85% |